Table 2.
Histopathological characteristics of IgAN patients
| P-value | ||||||
|---|---|---|---|---|---|---|
| Group 1 (n = 49) | Group 2 (n = 63) | Group 3 (n = 50) | 1 versus 2 | 1 versus 3 | 2 versus 3 | |
| M0/M1 | 47/2 | 50/13 | 25/25 | 0·011 | <0·001 | 0·001 |
| S0/S1 | 35/14 | 17/46 | 3/47 | <0·001 | <0·001 | 0·004 |
| E0/E1 | 40/9 | 39/24 | 20/30 | 0·023 | <0·001 | 0·021 |
| T0/T1/T2 | 48/1/0 | 27/29/7 | 2/20/28 | <0·001 | <0·001 | <0·001 |
According to the Oxford classification, four variables were evaluated; that is, mesangial proliferation (M), segmental glomerulosclerosis (S), endocapillary hypercellularity (E) and tubular atrophy/interstitial fibrosis (T). IgAN: immunoglobulin A nephropathy.